U.S., March 11 -- ClinicalTrials.gov registry received information related to the study (NCT06867419) titled 'Metabolic Features Effects on FAST Score in MASLD Patients' on Feb. 13.
Brief Summary: The goal of this observational cross-sectional study is to evaluate the effect of metabolic features on Fibroscan-AST (FAST) score stratification in metabolic dysfunction-associated steatotic liver disease (MASLD) patients in Egypt.
Researchers will identify the metabolic risk factors in patients with MASLD. evaluate the effect of metabolic features on stratifying MASLD patients by predicting higher FAST score.
Participants will be subjected to history taking, clinical examination, laboratory investigations, abdominal ultrasonography, and trans...